Clinical Features and Prognostic Impact of Coexpression Modules Constructed by WGCNA for Diffuse Large B-Cell Lymphoma

Figure 9

Validation of candidate prognostic miRNAs in independent datasets. The differences in expression patterns of hsa-miR-338 (a) and hsa-miR-891a (b) between DLBCL and controls. Overall survival analysis of hsa-miR-338 (c) and hsa-miR-891a (d) in DLBCL.

(a)

(b)

(c)

(d)